Merck & Co., Inc.
MRK
$130.72
$3.722.93%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 5.78% | 6.70% | 3.03% | -8.89% | 2.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.78% | 6.70% | 3.03% | -8.89% | 2.29% |
| Cost of Revenue | -1.25% | 9.05% | -3.78% | -26.94% | -5.97% |
| Gross Profit | 8.49% | 5.89% | 5.74% | 0.22% | 5.86% |
| SG&A Expenses | -14.76% | 2.69% | 3.30% | 8.34% | -16.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.51% | 2.17% | 111.56% | 4.48% | -19.65% |
| Operating Income | -99.74% | 15.65% | -192.44% | -32.08% | 125.44% |
| Income Before Tax | -158.24% | 56.85% | -218.90% | -24.91% | -10.13% |
| Income Tax Expenses | -265.66% | 163.64% | 18.40% | 48.92% | 482.35% |
| Earnings from Continuing Operations | -140.62% | 46.02% | -251.23% | -34.41% | -21.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 100.00% | 0.00% | 40.00% | -233.33% | 75.00% |
| Net Income | -140.64% | 46.09% | -251.50% | -34.55% | -19.72% |
| EBIT | -99.74% | 15.65% | -192.44% | -32.08% | 125.44% |
| EBITDA | -83.29% | 13.86% | -164.50% | -28.76% | 92.31% |
| EPS Basic | -140.68% | 45.86% | -251.02% | -34.81% | -20.00% |
| Normalized Basic EPS | -124.01% | 16.47% | -197.85% | -32.50% | 128.61% |
| EPS Diluted | -140.99% | 45.31% | -251.83% | -34.71% | -20.00% |
| Normalized Diluted EPS | -124.12% | 16.47% | -198.20% | -32.60% | 128.25% |
| Average Basic Shares Outstanding | -0.12% | 0.16% | 0.32% | 0.40% | 0.36% |
| Average Diluted Shares Outstanding | -0.59% | 0.16% | -0.04% | 0.55% | 0.51% |
| Dividend Per Share | 5.80% | 5.80% | 5.80% | 5.80% | 6.15% |
| Payout Ratio | -3.60% | -0.27% | -1.70% | 0.62% | 0.33% |
